THE PHARMACOKINETICS OF FLUCONAZOLE DURING HEMODIALYSIS IN UREMIC PATIENTS

被引:0
|
作者
OONO, S [1 ]
TABEI, K [1 ]
TETSUKA, T [1 ]
ASANO, Y [1 ]
机构
[1] JICHI MED SCH,DEPT MED,DIV NEPHROL,3311-1 MINAMIKAWACHI MACHI,MINAMI KAWACHI,TOCHIGI 32904,JAPAN
关键词
FLUCONAZOLE; HEMODIALYSIS; FUNGAL INFECTION; UREMIA PHARMACOKINETICS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We have studied the pharmacokinetics of fluconazole in five patients on long-term haemodialysis. The single-pass extraction rate of the dialyzer was 59 (3.5)% (n = 4), and the serum concentration was reduced by haemodialysis for 3 or 4 h by 26 (3.2)% (n = 5) and 39 (2.2)% (n = 9) respectively. The estimated amount extracted by a dialysis of 4 h was 33 (3.2)% (n = 4) of the dose. During repeated administration the serum fluconazole concentration increased, reaching a plateau at about 4 times the peak concentration after the first dose. After discontinuing administration the serum fluconazole concentration fell by 25% in every 3 h dialysis session. We conclude that fluconazole should be given in the usual dose of 100 or 200 mg at the end of every haemodialysis session.
引用
收藏
页码:667 / 670
页数:4
相关论文
共 50 条
  • [21] PHARMACOKINETICS AND BIOAVAILABILITY OF FLUCONAZOLE IN PATIENTS WITH AIDS
    DEMURIA, D
    FORREST, A
    RICH, J
    SCAVONE, JM
    COHEN, LG
    KAZANJIAN, PH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) : 2187 - 2192
  • [22] PHARMACOKINETICS OF FLUCONAZOLE IN PEDIATRIC-PATIENTS
    BRAMMER, KW
    COATES, PE
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (04) : 325 - 329
  • [23] FIBROSING UREMIC PLEURITIS DURING HEMODIALYSIS
    BROWN, CM
    SLOAN, DE
    BERNS, AS
    KANTER, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 245 (07): : 705 - 705
  • [24] FIBROSING UREMIC PLEURITIS DURING HEMODIALYSIS
    RODELAS, R
    RAKOWSKI, TA
    ARGY, WP
    SCHREINER, GE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (23): : 2424 - 2425
  • [25] PHARMACOKINETICS OF OFLOXACIN IN HEMODIALYSIS-PATIENTS DURING HEMODIALYSIS-TREATMENT AND DURING THE INTERDIALYTIC INTERVAL
    DORFLER, A
    SCHULZ, W
    BURKHARDT, F
    ZICHNER, M
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1987, 16 (10) : 443 - 453
  • [26] GASTRODUODENAL DISEASE IN UREMIC PATIENTS DURING HEMODIALYSIS-TREATMENT (HDT)
    FARINELLI, A
    MALACARNE, F
    FARINELLI, R
    SQUERZANTI, R
    GILLI, P
    TATARANNI, G
    GUALANDI, G
    KIDNEY INTERNATIONAL, 1985, 28 (02) : 331 - 331
  • [27] Impaired peripheral micro- and macrocirculation during hemodialysis in uremic patients
    Santesson, P.
    Danielsson, A.
    Iseda, I.
    Adamson, U.
    Lins, P. -E.
    Jorneskog, G.
    INTERNATIONAL ANGIOLOGY, 2010, 29 (04) : 362 - 370
  • [28] CHANGES IN ACID-BASE BALANCE OF UREMIC PATIENTS DURING HEMODIALYSIS
    WELLER, JM
    SWAN, RC
    MERRILL, JP
    JOURNAL OF CLINICAL INVESTIGATION, 1953, 32 (08): : 729 - 735
  • [29] AN ASSESSMENT OF THE EFFECTS OF IMPAIRED RENAL-FUNCTION AND HEMODIALYSIS ON THE PHARMACOKINETICS OF FLUCONAZOLE
    TOON, S
    ROSS, CE
    GOKAL, R
    ROWLAND, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (02) : 221 - 226
  • [30] MALE HYPOGONADISM OF UREMIC PATIENTS ON HEMODIALYSIS
    MASTROGIACOMO, I
    DEBESI, L
    ZUCCHETTA, P
    SERAFINI, E
    LAGRECA, G
    GASPAROTTO, ML
    LORENZI, S
    DEAN, P
    ARCHIVES OF ANDROLOGY, 1988, 20 (02): : 171 - 175